We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTI icon
151
British American Tobacco
BTI
$132B
$3.38M 0.1%
59,600
-526
-0.9% -$28.7K
CIEN icon
152
Ciena
CIEN
$55.3B
$3.36M 0.1%
14,383
+186
+1% +$36.1K
KB icon
153
KB Financial Group
KB
$41.2B
$3.36M 0.1%
39,069
-15,277
-28% -$1.29M
PH icon
154
Parker-Hannifin
PH
$125B
$3.27M 0.1%
3,717
-1
-0% -$818
BABA icon
155
Alibaba
BABA
$269B
$3.25M 0.1%
22,186
-14
-0.1% -$2.28K
CCJ icon
156
Cameco
CCJ
$38.3B
$3.23M 0.1%
35,305
-3
-0% -$270
PANW icon
157
Palo Alto Networks
PANW
$264B
$3.2M 0.1%
17,399
+310
+2% +$62.5K
APP icon
158
Applovin
APP
$132B
$3.2M 0.1%
4,744
+4,065
+599% +$2.56M
DUK icon
159
Duke Energy
DUK
$102B
$3.16M 0.1%
26,946
-58
-0.2% -$7.08K
MDT icon
160
Medtronic
MDT
$107B
$3.12M 0.09%
32,477
+101
+0.3% +$9.81K
BSX icon
161
Boston Scientific
BSX
$65.8B
$3.11M 0.09%
32,596
+296
+0.9% +$29K
TMUS icon
162
T-Mobile US
TMUS
$193B
$3.09M 0.09%
15,201
+2,100
+16% +$445K
TXN icon
163
Texas Instruments
TXN
$255B
$3.07M 0.09%
17,681
-4,282
-19% -$733K
SYK icon
164
Stryker
SYK
$127B
$3.05M 0.09%
8,690
+133
+2% +$48.5K
BDX icon
165
Becton Dickinson
BDX
$43.1B
$3.05M 0.09%
15,710
-14
-0.1% -$2.66K
NWG icon
166
NatWest
NWG
$71.5B
$3.03M 0.09%
173,409
-116
-0.1% -$1.84K
BX icon
167
Blackstone
BX
$104B
$3.03M 0.09%
19,660
+6,235
+46% +$947K
FN icon
168
Fabrinet
FN
$17.1B
$3.02M 0.09%
6,628
+47
+0.7% +$20.4K
KGC icon
169
Kinross Gold
KGC
$28.5B
$2.98M 0.09%
106,001
ITW icon
170
Illinois Tool Works
ITW
$81.4B
$2.98M 0.09%
12,094
-1,209
-9% -$301K
ING icon
171
ING
ING
$93.8B
$2.97M 0.09%
106,170
+374
+0.4% +$9.64K
WELL icon
172
Welltower
WELL
$178B
$2.97M 0.09%
15,987
+109
+0.7% +$20.4K
BMO icon
173
Bank of Montreal
BMO
$125B
$2.96M 0.09%
22,807
MCO icon
174
Moody's
MCO
$81.7B
$2.91M 0.09%
5,706
+807
+16% +$394K
HCA icon
175
HCA Healthcare
HCA
$84.8B
$2.91M 0.09%
6,243
-5
-0.1% -$2.32K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.